Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure : prevalence, risk factors and prognostic impact: A prospective observational study
Copyright ©ERS 2018..
Dyspnoea is a frequent and intense symptom in intubated patients, but little attention has been paid to dyspnoea during noninvasive mechanical ventilation in the intensive care unit (ICU).The objectives of this study were to quantify the prevalence, intensity and prognostic impact of dyspnoea in patients receiving noninvasive ventilation (NIV) for acute respiratory failure (ARF) based on secondary analysis of a prospective observational cohort study in patients who received ventilatory support for ARF in 54 ICUs in France and Belgium. Dyspnoea was measured by a modified Borg scale.Among the 426 patients included, the median (interquartile range) dyspnoea score was 4 (3-5) on admission and 3 (2-4) after the first NIV session (p=0.001). Dyspnoea intensity ≥4 after the first NIV session was associated with the Sequential Organ Failure Assessment Score (odds ratio (OR) 1.12, p=0.001), respiratory rate (OR 1.03, p=0.032), anxiety (OR 1.92, p=0.006), leaks (OR 2.5, p=0.002) and arterial carbon dioxide tension (OR 0.98, p=0.025). Dyspnoea intensity ≥4 was independently associated with NIV failure (OR 2.41, p=0.001) and mortality (OR 2.11, p=0.009), but not with higher post-ICU burden and altered quality of life.Dyspnoea is frequent and intense in patients receiving NIV for ARF and is associated with a higher risk of NIV failure and poorer outcome.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
The European respiratory journal - 52(2018), 2 vom: 05. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dangers, Laurence [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 20.06.2019 Date Revised 20.06.2019 published: Electronic-Print ClinicalTrials.gov: NCT01449331 CommentIn: Eur Respir J. 2018 Aug 9;52(2):. - PMID 30093558 Citation Status MEDLINE |
|---|
| doi: |
10.1183/13993003.02637-2017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM286194678 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM286194678 | ||
| 003 | DE-627 | ||
| 005 | 20231225051126.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.02637-2017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0953.xml |
| 035 | |a (DE-627)NLM286194678 | ||
| 035 | |a (NLM)29976650 | ||
| 035 | |a (PII)1702637 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dangers, Laurence |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure |b prevalence, risk factors and prognostic impact: A prospective observational study |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.06.2019 | ||
| 500 | |a Date Revised 20.06.2019 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a ClinicalTrials.gov: NCT01449331 | ||
| 500 | |a CommentIn: Eur Respir J. 2018 Aug 9;52(2):. - PMID 30093558 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright ©ERS 2018. | ||
| 520 | |a Dyspnoea is a frequent and intense symptom in intubated patients, but little attention has been paid to dyspnoea during noninvasive mechanical ventilation in the intensive care unit (ICU).The objectives of this study were to quantify the prevalence, intensity and prognostic impact of dyspnoea in patients receiving noninvasive ventilation (NIV) for acute respiratory failure (ARF) based on secondary analysis of a prospective observational cohort study in patients who received ventilatory support for ARF in 54 ICUs in France and Belgium. Dyspnoea was measured by a modified Borg scale.Among the 426 patients included, the median (interquartile range) dyspnoea score was 4 (3-5) on admission and 3 (2-4) after the first NIV session (p=0.001). Dyspnoea intensity ≥4 after the first NIV session was associated with the Sequential Organ Failure Assessment Score (odds ratio (OR) 1.12, p=0.001), respiratory rate (OR 1.03, p=0.032), anxiety (OR 1.92, p=0.006), leaks (OR 2.5, p=0.002) and arterial carbon dioxide tension (OR 0.98, p=0.025). Dyspnoea intensity ≥4 was independently associated with NIV failure (OR 2.41, p=0.001) and mortality (OR 2.11, p=0.009), but not with higher post-ICU burden and altered quality of life.Dyspnoea is frequent and intense in patients receiving NIV for ARF and is associated with a higher risk of NIV failure and poorer outcome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Montlahuc, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Kouatchet, Achille |e verfasserin |4 aut | |
| 700 | 1 | |a Jaber, Samir |e verfasserin |4 aut | |
| 700 | 1 | |a Meziani, Ferhat |e verfasserin |4 aut | |
| 700 | 1 | |a Perbet, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Similowski, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Resche-Rigon, Matthieu |e verfasserin |4 aut | |
| 700 | 1 | |a Azoulay, Elie |e verfasserin |4 aut | |
| 700 | 1 | |a Demoule, Alexandre |e verfasserin |4 aut | |
| 700 | 0 | |a REVA Network (Research Network in Mechanical Ventilation) and the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (GrrrOH) |e verfasserin |4 aut | |
| 700 | 0 | |a List of contributors who included study patients: Angers University Hospital, Angers, France: |e verfasserin |4 aut | |
| 700 | 1 | |a Kouatchet, A |e investigator |4 oth | |
| 700 | 1 | |a Mercat, A |e investigator |4 oth | |
| 700 | 1 | |a Mortaza, S |e investigator |4 oth | |
| 700 | 1 | |a Vargas, F |e investigator |4 oth | |
| 700 | 1 | |a Guisset, O |e investigator |4 oth | |
| 700 | 1 | |a Bodson, L |e investigator |4 oth | |
| 700 | 1 | |a Charron, C |e investigator |4 oth | |
| 700 | 1 | |a Tchenio, X |e investigator |4 oth | |
| 700 | 1 | |a Andrivet, P |e investigator |4 oth | |
| 700 | 1 | |a Hamrouni, M |e investigator |4 oth | |
| 700 | 1 | |a Kalfon, P |e investigator |4 oth | |
| 700 | 1 | |a Jacobs, O |e investigator |4 oth | |
| 700 | 1 | |a Souweine, B |e investigator |4 oth | |
| 700 | 1 | |a Perbet, S |e investigator |4 oth | |
| 700 | 1 | |a Constantin, J M |e investigator |4 oth | |
| 700 | 1 | |a Clergue, C |e investigator |4 oth | |
| 700 | 1 | |a Perez, D |e investigator |4 oth | |
| 700 | 1 | |a Aboab, J |e investigator |4 oth | |
| 700 | 1 | |a Miloud, G |e investigator |4 oth | |
| 700 | 1 | |a Camous, L |e investigator |4 oth | |
| 700 | 1 | |a Osman, D |e investigator |4 oth | |
| 700 | 1 | |a Quinio, P |e investigator |4 oth | |
| 700 | 1 | |a Kilani, S |e investigator |4 oth | |
| 700 | 1 | |a Bourdin, G |e investigator |4 oth | |
| 700 | 1 | |a Guerin, C |e investigator |4 oth | |
| 700 | 1 | |a Castanier, M |e investigator |4 oth | |
| 700 | 1 | |a Papazian, L |e investigator |4 oth | |
| 700 | 1 | |a Eon, B |e investigator |4 oth | |
| 700 | 1 | |a Gainnier, M |e investigator |4 oth | |
| 700 | 1 | |a Lambert, D |e investigator |4 oth | |
| 700 | 1 | |a Joos, W |e investigator |4 oth | |
| 700 | 1 | |a Forceville, X |e investigator |4 oth | |
| 700 | 1 | |a Martin, J |e investigator |4 oth | |
| 700 | 1 | |a Jochmans, S |e investigator |4 oth | |
| 700 | 1 | |a Corne, P |e investigator |4 oth | |
| 700 | 1 | |a Carr, J |e investigator |4 oth | |
| 700 | 1 | |a Conseil, M |e investigator |4 oth | |
| 700 | 1 | |a Jaber, S |e investigator |4 oth | |
| 700 | 1 | |a Das, V |e investigator |4 oth | |
| 700 | 1 | |a Conrad, M |e investigator |4 oth | |
| 700 | 1 | |a Brule, N |e investigator |4 oth | |
| 700 | 1 | |a Dellamonica, J |e investigator |4 oth | |
| 700 | 1 | |a Demoule, A |e investigator |4 oth | |
| 700 | 1 | |a Schmidt, M |e investigator |4 oth | |
| 700 | 1 | |a Lefrant, J Y |e investigator |4 oth | |
| 700 | 1 | |a Rabbat, A |e investigator |4 oth | |
| 700 | 1 | |a Zuber, B |e investigator |4 oth | |
| 700 | 1 | |a Mira, J P |e investigator |4 oth | |
| 700 | 1 | |a Guerot, E |e investigator |4 oth | |
| 700 | 1 | |a Bart, F |e investigator |4 oth | |
| 700 | 1 | |a Legrand, M |e investigator |4 oth | |
| 700 | 1 | |a Richecoeur, J |e investigator |4 oth | |
| 700 | 1 | |a Cousson, J |e investigator |4 oth | |
| 700 | 1 | |a Chatellier, D |e investigator |4 oth | |
| 700 | 1 | |a Drault, J N |e investigator |4 oth | |
| 700 | 1 | |a Picard, W |e investigator |4 oth | |
| 700 | 1 | |a Fartoukh, M |e investigator |4 oth | |
| 700 | 1 | |a Messika, J |e investigator |4 oth | |
| 700 | 1 | |a Azoulay, E |e investigator |4 oth | |
| 700 | 1 | |a Schnell, D |e investigator |4 oth | |
| 700 | 1 | |a Maury, E |e investigator |4 oth | |
| 700 | 1 | |a Alves, M |e investigator |4 oth | |
| 700 | 1 | |a Garrouste-Orgeas, M |e investigator |4 oth | |
| 700 | 1 | |a Misset, B |e investigator |4 oth | |
| 700 | 1 | |a Touati, S |e investigator |4 oth | |
| 700 | 1 | |a Beuret, P |e investigator |4 oth | |
| 700 | 1 | |a Fabre, X |e investigator |4 oth | |
| 700 | 1 | |a Herbecq, P |e investigator |4 oth | |
| 700 | 1 | |a Botoc, V |e investigator |4 oth | |
| 700 | 1 | |a Chevalier, S |e investigator |4 oth | |
| 700 | 1 | |a Collet, F |e investigator |4 oth | |
| 700 | 1 | |a Castelain, V |e investigator |4 oth | |
| 700 | 1 | |a Janssen-Langenstein, R |e investigator |4 oth | |
| 700 | 1 | |a Meziani, F |e investigator |4 oth | |
| 700 | 1 | |a Dumoussaud, N |e investigator |4 oth | |
| 700 | 1 | |a Rahmani, H |e investigator |4 oth | |
| 700 | 1 | |a Legriel, S |e investigator |4 oth | |
| 700 | 1 | |a Massere, E |e investigator |4 oth | |
| 700 | 1 | |a Georges, H |e investigator |4 oth | |
| 700 | 1 | |a Arnal, J M |e investigator |4 oth | |
| 700 | 1 | |a Meert, A P |e investigator |4 oth | |
| 700 | 1 | |a Devriendt, J |e investigator |4 oth | |
| 700 | 1 | |a Deschamps, P |e investigator |4 oth | |
| 700 | 1 | |a Depuyt, P |e investigator |4 oth | |
| 700 | 1 | |a Benoit, D |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d 1989 |g 52(2018), 2 vom: 05. Aug. |w (DE-627)NLM012664782 |x 0903-1936 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2018 |g number:2 |g day:05 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1183/13993003.02637-2017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2018 |e 2 |b 05 |c 08 | ||